Xuening dripping pill having hemostatic function and its preparing method

A technology for hemostasis and dripping pills, which is used in medical preparations containing active ingredients, pill delivery, blood diseases, etc. It is beneficial to labor protection and environmental protection, improving bioavailability, and no dust pollution.
CN1682931AInactive Publication Date: 2005-10-19北京博智绿洲医药科技有限公司

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
北京博智绿洲医药科技有限公司
Publication Date
2005-10-19
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The present invention relates to a kind of medicine composition, Xuening dripping pill, with functions of arresting bleeding and for auxiliary treatment of hemophilia, thromboctopenia, purpura, nosebleeding, etc. The present invention has high bioavailability, fast medicine release, fast acting, high effective content, taking convenience and low cost, and the production process has no pollution. The Xuening dripping pill is prepared with peanut coat as one kind of Chinese medicinal material and medicine carrier as matrix.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a pharmaceutical composition with hemostatic effect, which is used for auxiliary treatment of diseases such as hemophilia, thrombocytopenia, purpura, epistaxis, bleeding gums, etc., especially relates to the preparation of traditional Chinese medicine peanut shells for the above diseases A pharmaceutical composition oral preparation. Background technique

[0002] According to the ministerial drug standard WS 3 - Xuening granule prepared by the preparation method given in B-0927-91 is a kind of oral medicine that has hemostatic effect and is used for adjuvant treatment of hemophilia, thrombocytopenia, purpura, epistaxis, gingival bleeding and other diseases Granules, clinically proven, have definite curative effects, and are commonly used medicines for clinical and family treatment of such diseases.

[0003] The following is the drug standard WS 3 - Formula and process and brief description given in B-0927-91:

[0004] Prepa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More